Rockefeller Capital Management L.P. Pacific Biosciences Of California, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$5.67 - $11.2 $2,988 - $5,902	527 Added 107.33%	1,018 $8,000
Q3 2022 Nov 02, 2022	SELL	$3.93 - $8.57 $3,246 - $7,078	-826 Reduced 62.72%	491 $2,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $303,827 - $788,288	-75,579 Reduced 98.29%	1,317 $4,000
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $645,586 - $1.6 Million	76,582 Added 24389.17%	76,896 $699,000
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $6,047 - $9,445	314 New	314 $5,000
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $109,707 - $154,543	-4,413 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$22.3 - $36.02 $10,280 - $16,605	-461 Reduced 9.46%	4,413 $153,000
Q1 2021 May 11, 2021	SELL	$26.38 - $51.15 $38,409 - $74,474	-1,456 Reduced 23.0%	4,874 $161,000
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $66,465 - $180,405	6,330 New	6,330 $164,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.